Our Scientific Evidence
Driven by science to develop and deliver innovative products and Solutions.
We believe in sharing our scientific findings and are committed to cooperation with external partners, physicians and their organizations. Our scientific publications are available to all relevant parties
Reviews and Guidelines
Rozzanigo et al., 20231 (review on DSM-TACE)
Rozzanigo, U. et al. Chemoembolization with Degradable Starch Microspheres (DSM-TACE). Expanding indications in HCC multidisciplinary tumor board. Hepatoma Research 9, 14; 10.20517/2394-5079.2022.66 (2023). Concerns Spherex®, manufactured by Kabi Pharmacia and EmboCept® S, manufactured by Serumwerk Bernburg AG. Explore more →
Lucatelli et al., 20212 (CIRSE-guidelines)
Treatment of hepatocellular carcinoma (HCC):
Auer et al., 20213
Ludwig et al., 20214 Explore more →
Orlaccio et al., 20205
Minici et al., 20216 Explore more →
Treatment of intrahepatic cholangiocellular carcinoma (ICC):
Goerg et al., 20198
Treatment of colorectal carcinoma (CRC) metastases in the liver:
Vogl et al., 20217
Treatment of lung tumors:
Vogl et al., 20199
